| Risk | Moderately High |
|---|---|
| Min SIP Amount | ₹500 |
| Expense Ratio | 1.00% |
| NAV | ₹39.21 (01 Jul 2020) |
|---|---|
| Fund Started | 01 Jan 2013 |
| Fund Size | ₹6,498 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Ipca Laboratories Ltd. | Healthcare | Equity | 4.6% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 3.8% |
| Balkrishna Industries Ltd. | Automobile | Equity | 3.7% |
| Coromandel International Ltd. | Chemicals | Equity | 3.7% |
| Bata India Ltd. | FMCG | Equity | 3.2% |
| Atul Ltd. | Chemicals | Equity | 3.2% |
| Infosys Ltd. | Technology | Equity | 3.2% |
| The Ramco Cements Ltd. | Construction | Equity | 3.2% |
| Manappuram Finance Ltd. | Financial | Equity | 3.1% |
| Exide Industries Ltd. | Engineering | Equity | 3.0% |
DSP Midcap Direct Plan Dividend is a Equity Mutual Fund Scheme launched by DSP BlackRock Mutual Fund. This scheme was made available to investors on 01 Jan 2013. Vinit Sambre, Jay Kothari, Resham Jain is the Current Fund Manager of DSP Midcap Direct Plan Dividend fund.The fund currently has an Asset Under Management(AUM) of ₹6,498 Cr and the Latest NAV as of 01 Jul 2020 is ₹39.21.
The DSP Midcap Direct Plan Dividend is rated Moderately High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 500. Exit load of 1% if redeemed less than 12 months
An Open ended equity growth scheme, primarily seeking to generate long term capital appreciation from a portfolio substantially constituted of equity and equity related securities, which are not part of top 100 stocks by market capitalization. From time to time, the Investment Manager will also seek participation in other equity and equity related securities to achieve optimal portfolio construction.